Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Night Blindness

3,4-dihydroxyphenylacetic acid has been researched along with Night Blindness in 1 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Night Blindness: Failure or imperfection of vision at night or in dim light, with good vision only on bright days. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pardue, MT1
Faulkner, AE1
Fernandes, A1
Yin, H1
Schaeffel, F1
Williams, RW1
Pozdeyev, N1
Iuvone, PM1

Other Studies

1 other study available for 3,4-dihydroxyphenylacetic acid and Night Blindness

ArticleYear
High susceptibility to experimental myopia in a mouse model with a retinal on pathway defect.
    Investigative ophthalmology & visual science, 2008, Volume: 49, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, High Pressure Liquid; Disease Models, Anima

2008